Black Rock Inc. Lannett CO Inc Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.45 - $0.86 $333 - $636	-740 Reduced 0.13%	573,682 $298,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $0.63 $821 - $1,125	-1,786 Reduced 0.31%	574,422 $258,000
Q2 2022 Aug 12, 2022	SELL	$0.47 - $0.87 $38,600 - $71,451	-82,128 Reduced 12.48%	576,208 $334,000
Q1 2022 May 12, 2022	SELL	$0.75 - $1.77 $3,353 - $7,913	-4,471 Reduced 0.67%	658,336 $519,000
Q4 2021 Feb 10, 2022	BUY	$1.56 - $2.93 $6,865 - $12,894	4,401 Added 0.67%	662,807 $1.07 Million
Q3 2021 Nov 09, 2021	SELL	$2.91 - $4.83 $38,755 - $64,325	-13,318 Reduced 1.98%	658,406 $1.98 Million
Q2 2021 Aug 11, 2021	BUY	$4.17 - $5.74 $2.8 Million - $3.86 Million	671,724 New	671,724 $3.14 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.